MedTrace Logo

2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy

NCT02091050 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-08-31

No results posted yet for this study

Summary

Demonstrate the limitations of conventional dosimetry (2D) for the adjuvant brachytherapy treatment and assess whether tridimensional dosimetry relates more faithfully with the occurrence of adverse effects.

Conditions

Interventions

OTHER

2D HDR planning

HDR planning using simple radiograph (2D)

OTHER

3D HDR planning

HDR planning using computed tomography (3D)

Sponsors & Collaborators

  • AC Camargo Cancer Center

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-03-31
Completion
2017-01-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02091050 on ClinicalTrials.gov